Free Trial
→ The Iran War Just Broke the Gold Market (From Behind the Markets) (Ad)tc pixel Free GMAB Stock Alerts

Genmab A/S (GMAB) Short Interest Ratio & Short Volume

Genmab A/S logo
$27.53 +0.49 (+1.80%)
Closing price 05/5/2026 03:59 PM Eastern
Extended Trading
$27.53 +0.00 (+0.01%)
As of 05/5/2026 07:11 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Genmab A/S Short Interest Overview

As of April 15, 2026, Genmab A/S (GMAB) had a short interest of 7.93 million shares sold short, representing 1.25% of the public float. This marks a -7.59% decrease in short interest since the prior report. The short interest ratio (days to cover) is 5.4, meaning it would take 5.4 days of the average trading volume of 1.63 million shares to cover all short positions.

Current Short Interest
7,925,760 shares
Previous Short Interest
8,576,449 shares
Change Vs. Previous Month
-7.59%
Dollar Volume Sold Short
$232.22 million
Short Interest Ratio
5.4 Days to Cover
Last Record Date
April 15, 2026
Outstanding Shares
623,510,000 shares
Short Percent of Float
1.25%
Today's Trading Volume
1,179,899 shares
Average Trading Volume
1,626,589 shares
Today's Volume Vs. Average
73%
Short Selling Genmab A/S?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Genmab A/S and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

GMAB Short Interest Over Time

GMAB Days to Cover Over Time

GMAB Percentage of Float Shorted Over Time

Genmab A/S Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/15/20267,925,760 shares $232.22 million -7.6%1.3%5.4 $29.30
3/31/20268,576,449 shares $230.11 million -3.6%1.4%5.51 $26.83
3/13/20268,899,874 shares $232.64 million +2.3%1.4%5.49 $26.14
2/27/20268,699,348 shares $256.11 million +10.1%1.4%4.62 $29.44
2/13/20267,901,228 shares $237.27 million -6.1%1.2%6.23 $30.03
1/30/20268,413,829 shares $274.54 million -15.1%1.3%3.91 $32.63
1/15/20269,908,231 shares $335.39 million -11.0%1.6%5.59 $33.85
12/31/202511,130,671 shares $342.82 million -3.2%1.8%7.92 $30.80
12/15/202511,499,724 shares $363.05 million -3.3%1.8%7.98 $31.57
11/28/202511,896,539 shares $385.03 million +5.4%1.9%8.53 $32.37
11/14/202511,292,884 shares $341.72 million +7.2%1.8%5.41 $30.26
10/31/202510,539,384 shares $301.53 million +57.9%1.7%4.12 $28.61
10/15/20256,680,000 shares $218.57 million +20.1%1.1%3.6 $32.72
9/30/20255,560,000 shares $170.53 million +59.3%0.9%3.5 $30.67
9/15/20253,490,000 shares $97.69 million -9.4%0.6%2.6 $27.99
8/31/20253,850,000 shares $95.75 million +12.9%0.6%2.8 $24.87
8/15/20253,410,000 shares $79.49 million -5.0%0.6%2.6 $23.31
7/31/20253,590,000 shares $77.80 million -1.9%0.6%2.6 $21.67
7/15/20253,660,000 shares $77.41 million +109.1%0.6%2.6 $21.15
6/30/20251,750,000 shares $36.16 million -21.5%0.3%1.2 $20.66
6/15/20252,230,000 shares $50.89 million -8.2%0.4%1.4 $22.82
5/31/20252,430,000 shares $50.86 million -11.6%0.4%1.6 $20.93
5/15/20252,750,000 shares $54.04 million +15.1%0.5%1.8 $19.65
4/30/20252,390,000 shares $50.55 million +18.3%0.4%1.6 $21.15
4/15/20252,020,000 shares $39.41 million -6.1%0.3%1.3 $19.51
3/31/20252,150,000 shares $42.10 million -29.7%0.3%1.4 $19.58
3/15/20253,060,000 shares $62.76 million +32.5%0.5%2.1 $20.51
2/28/20252,310,000 shares $52.37 million +40.0%0.4%1.7 $22.67
2/15/20251,650,000 shares $35.15 million +1.9%0.3%1.2 $21.30
1/31/20251,620,000 shares $31.87 million -6.4%0.3%1.2 $19.67
1/15/20251,730,000 shares $35.00 million +25.4%0.3%1.4 $20.23
12/31/20241,380,000 shares $28.80 million -25.8%0.2%1.1 $20.87
12/15/20241,860,000 shares $37.52 million -7.9%0.3%1.5 $20.17
11/30/20242,020,000 shares $43.43 million -11.4%0.3%1.8 $21.50
11/15/20242,280,000 shares $46.95 million -2.6%0.4%2.1 $20.59
10/31/20242,340,000 shares $52.23 million +23.2%0.4%2.7 $22.32
10/15/20241,900,000 shares $44.04 million -15.9%0.3%2.6 $23.18
9/30/20242,260,000 shares $55.10 million +8.7%0.4%3.6 $24.38
9/15/20242,080,000 shares $55.95 million -2.4%0.3%3.6 $26.90
8/31/20242,130,000 shares $59.21 million -1.8%0.3%3.6 $27.80
8/15/20242,170,000 shares $59.05 million -26.7%0.3%3.6 $27.21
7/31/20242,960,000 shares $83.74 million +33.3%0.5%4.9 $28.29
7/15/20242,220,000 shares $58.92 million -3.5%0.3%3.9 $26.54
6/30/20242,300,000 shares $57.80 million -8.4%0.4%4.7 $25.13
6/15/20242,510,000 shares $65.74 million -12.5%0.4%5.2 $26.19
5/31/20242,870,000 shares $80.93 million -3.0%0.4%6.1 $28.20
5/15/20242,960,000 shares $89.45 million +7.6%0.5%5.7 $30.22
4/30/20242,750,000 shares $76.15 million +4.6%0.4%4.9 $27.69
4/15/20242,630,000 shares $77.61 million +9.6%0.4%4.6 $29.51
3/31/20242,400,000 shares $71.78 million +17.1%0.4%3.8 $29.91
3/15/20242,050,000 shares $61.38 million +10.2%0.3%3.3 $29.94
2/29/20241,860,000 shares $51.65 million -19.5%0.3%2.9 $27.77
2/15/20242,310,000 shares $65.21 million +12.7%0.4%3.7 $28.23
1/31/20242,050,000 shares $56.60 million +9.6%0.3%3.1 $27.61
1/15/20241,870,000 shares $59.11 million +7.5%N/A2.4 $31.61
12/31/20231,740,000 shares $55.40 million +8.8%N/A2.1 $31.84
12/15/20231,600,000 shares $49.38 million +8.1%N/A1.9 $30.86
11/30/20231,480,000 shares $46.78 million -3.3%N/A1.8 $31.61
11/15/20231,530,000 shares $48.52 million -15.9%N/A1.9 $31.71
10/31/20231,820,000 shares $51.69 million -22.6%0.3%2.6 $28.40
10/15/20232,350,000 shares $75.86 million -10.0%N/A3.6 $32.28
9/30/20232,610,000 shares $92.05 million -2.6%N/A5.3 $35.27
9/15/20232,680,000 shares $101.79 million -7.3%N/A5.4 $37.98
8/31/20232,890,000 shares $110.66 million -16.2%N/A6 $38.29
8/15/20233,450,000 shares $128.31 million -17.7%N/A7.3 $37.19
7/31/20234,190,000 shares $173.30 million +7.4%N/A8.7 $41.36
7/15/20233,900,000 shares $156.08 million +1.8%N/A8.9 $40.02
6/30/20233,830,000 shares $145.58 million +13.3%N/A9.5 $38.01
6/15/20233,380,000 shares $130.98 million -6.4%N/A8.8 $38.75
5/31/20233,610,000 shares $141.55 million +6.8%N/A8.9 $39.21
5/15/20233,380,000 shares $142.43 million -4.5%N/A7.2 $42.14
4/30/20233,540,000 shares $145.18 million +1.7%N/A7.6 $41.01
4/15/20233,480,000 shares $144.70 million +0.3%N/A7 $41.58
3/31/20233,470,000 shares $131.03 million +12.3%N/A6.7 $37.76
3/15/20233,090,000 shares $110.34 million +7.3%N/A5.6 $35.71
2/28/20232,880,000 shares $108.17 million -4.6%N/A4.6 $37.56
2/15/20233,020,000 shares $119.95 million +1.3%N/A4.9 $39.72
1/31/20232,980,000 shares $116.67 million -4.8%0.5%4.6 $39.15
1/15/20233,130,000 shares $125.70 million -4.9%N/A4.6 $40.16
12/30/20223,290,000 shares $139.43 million +2.5%N/A5 $42.38
12/15/20223,210,000 shares $143.68 million -13.7%N/A4.6 $44.76
11/30/20223,720,000 shares $173.09 million +8.1%N/A6.1 $46.53
11/15/20223,440,000 shares $148.26 million +0.3%N/A5.9 $43.10
10/31/20223,430,000 shares $132.09 million -5.0%N/A6 $38.51
10/15/20223,610,000 shares $131.77 million +0.8%N/A6 $36.50
9/30/20223,580,000 shares $115.03 million +12.6%N/A5.9 $32.13
9/15/20223,180,000 shares $115.82 million +8.5%N/A5.5 $36.42
8/31/20222,930,000 shares $103.99 million -19.7%N/A4.9 $35.49
8/15/20223,650,000 shares $135.93 million +37.2%N/A5.8 $37.24
7/31/20222,660,000 shares $94.75 million +15.7%N/A3.8 $35.62
7/15/20222,300,000 shares $78.91 million +1.8%N/A3.4 $34.31
6/30/20222,260,000 shares $73.43 million -8.9%N/A3.3 $32.49
6/15/20222,480,000 shares $68.65 million +3.8%N/A3.7 $27.68
5/31/20222,390,000 shares $72.30 million +4.4%N/A3.6 $30.25
5/15/20222,290,000 shares $67.14 million +30.1%N/A3.4 $29.32
4/30/20221,760,000 shares $61.92 million +9.3%N/A2.7 $35.18
4/15/20221,610,000 shares $59.17 million -5.3%N/A2.5 $36.75
3/31/20221,700,000 shares $61.51 million -21.7%N/A2.8 $36.18
3/15/20222,170,000 shares $72.72 million -8.4%N/A3.8 $33.51
2/28/20222,370,000 shares $79.30 million -19.9%N/A4 $33.46
2/15/20222,960,000 shares $100.34 million +1.7%N/A5.2 $33.90
1/31/20222,910,000 shares $99.17 million +26.5%N/A5.5 $34.08
1/15/20222,300,000 shares $82.11 million +4.1%N/A4.9 $35.70
12/31/20212,210,000 shares $87.43 million +6.3%N/A5.3 $39.56
12/15/20212,080,000 shares $75.92 million +8.3%N/A5.2 $36.50
11/30/20211,920,000 shares $73.96 million +34.3%N/A5.2 $38.52
11/15/20211,430,000 shares $58.87 million +12.6%N/A4 $41.17
10/29/20211,270,000 shares $56.69 million +1.6%N/A3.6 $44.64
10/15/20211,250,000 shares $55.54 million +15.7%N/A3.6 $44.43
9/30/20211,080,000 shares $47.20 million +1.9%N/A3 $43.70
9/15/20211,060,000 shares $45.43 million -10.9%N/A2.9 $42.86
8/31/20211,190,000 shares $56.39 million -26.1%N/A2.5 $47.39
8/13/20211,610,000 shares $74.98 million -4.2%N/A3.3 $46.57
7/30/20211,680,000 shares $75.70 million +3.1%N/A3.5 $45.06
7/15/20211,630,000 shares $70.29 million +14.8%N/A3.3 $43.12
6/30/20211,420,000 shares $57.98 million +54.5%N/A2.8 $40.83
6/15/2021918,900 shares $40.45 million +11.8%N/A1.8 $44.02
5/28/2021822,100 shares $33.39 million +7.5%N/A1.8 $40.62
5/14/2021764,800 shares $28.07 million +22.1%N/A1.3 $36.70

GMAB Short Interest - Frequently Asked Questions

What is Genmab A/S's current short interest?

Short interest is the volume of Genmab A/S shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 7,925,760 shares of GMAB short. 1.25% of Genmab A/S's shares are currently sold short. Learn More on Genmab A/S's current short interest.

What is a good short interest ratio for Genmab A/S?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. GMAB shares currently have a short interest ratio of 5.4. Learn More on Genmab A/S's short interest ratio.

Which institutional investors are shorting Genmab A/S?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Genmab A/S: Jane Street Group LLC, Group One Trading LLC, and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Genmab A/S?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.25% of Genmab A/S's floating shares are currently sold short.

Is Genmab A/S's short interest increasing or decreasing?

Genmab A/S saw a decline in short interest in the month of April. As of April 15th, there was short interest totaling 7,925,760 shares, a decline of 7.6% from the previous total of 8,576,449 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Genmab A/S's short interest compare to its competitors?

1.25% of Genmab A/S's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Genmab A/S: Takeda Pharmaceutical Co. (0.33%), argenex SE (3.76%), Teva Pharmaceutical Industries Ltd. (4.07%), BeOne Medicines Ltd. - Sponsored ADR (1.13%), Insmed, Inc. (6.56%), Revolution Medicines, Inc. (7.36%), BioNTech SE Sponsored ADR (1.58%), Moderna, Inc. (16.87%), Roivant Sciences Ltd. (3.83%), Summit Therapeutics PLC (29.44%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($87.50 billion), Invesco QQQ ($42.26 billion), iShares Russell 2000 ETF ($24.79 billion), Salesforce Inc. ($13.16 billion), SPDR S&P Biotech ETF ($10.01 billion), Western Digital Corporation ($9.77 billion), Sandisk Corporation ($8.69 billion), iShares 20+ Year Treasury Bond ETF ($8.06 billion), CoreWeave Inc. ($7.67 billion), and iShares iBoxx $ High Yield Corporate Bond ETF ($7.64 billion). View all of the most shorted stocks.

What does it mean to sell short Genmab A/S stock?

Short selling GMAB is an investing strategy that aims to generate trading profit from Genmab A/S as its price is falling. GMAB shares are trading up $0.49 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Genmab A/S?

A short squeeze for Genmab A/S occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of GMAB, which in turn drives the price of the stock up even further.

How often is Genmab A/S's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GMAB, twice per month. The most recent reporting period available is April, 15 2026.

What do GMAB's short interest metrics mean?

Understanding short interest metrics can help you assess how traders are positioning around a stock like GMAB:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.



Related Companies
Short Interest Tools

This page (NASDAQ:GMAB) was last updated on 5/6/2026 by MarketBeat.com Staff.
From Our Partners
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
I’m sounding the alarm
Meta is cutting 10% of its workforce. Microsoft offered voluntary retirement to 7% of U.S. employees. Oracle, ...
Porter & Company | Sponsoredtc pixel
PH: Do THESE 4 things to your bank account now …
In a few short months, the US government could gain unprecedented powers over personal bank accounts - includi...
Weiss Ratings | Sponsoredtc pixel
How to collect $1,170/month from silver
There is a silver fund paying up to 20% in yearly distributions - no mining stocks, no options required. The s...
Investors Alley | Sponsoredtc pixel
Satellite Images Spot Potential $10 Trillion Discovery
'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...
Altimetry | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
A U.S. Resource Gap Is a National Issue - and Opportunity
America still does not domestically produce one mineral tied to batteries, energy storage, and national defens...
i2i Marketing Group, LLC | Sponsoredtc pixel